Medicine
Clinical study on the treatment of fatal hepatitis with artificial liver support system
Jian-Wei Deng
tlooto Summary
The ALSS treatment will effectively remove the pathological compositions, including total bilirubin(TBIL),NH 3,tumor necrosis factorα and endotoxin, out of the liver associated with fatal hepatitis, and it is available to improve the survival rate and reduce the mortality rate in patients with fatal liver disease.
Abstract
Abstract is not available.
Citation format
DENG, Jian-Wei. Clinical study on the treatment of fatal hepatitis with artificial liver support system. Chinese Critical Care Medicine, 2000.